MBD3 and familial pancreatic carcinoma: In pancreatic cancer, MBD3 can inhibit the epithelial–mesenchymal transition (EMT) process through TGF-β/Smad signaling transduction [10] and suppress the stemness of pancreatic cancer cells through the Hippo pathway [11].